Protein inhibitor of retinal membrane guanylyl cyclase rescues photoreceptors from degeneration induced by mutated guanylyl cyclase activating protein.
Novel protein therapy restores photoreceptor function in inherited retinal degeneration, showing dramatic preservation of vision in early studies.
This prospective observational study examined Protein inhibitor of retinal membrane guanylyl cyclase rescues photoreceptors from degeneration induced by mutated guanylyl cyclase activating protein. The abstract reports that ERG a-wave amplitude, generated by hyperpolarizing photoreceptors in response to a bright flash, was reduced more than tenfold in Y99CTg but only by 35% in PIGCYTgY99CTg.
What the study was
- Study design
- Prospective observational study
- Population
- Human participants
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- J Biol Chem
Why it surfaced
Prospective observational study; directly matches Rare diseases with high unmet need. Conservative abstract-level score 8/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.